Advertisement

Molecular Medicine

, Volume 17, Issue 1–2, pp 2–3 | Cite as

“Merinoff Symposium 2010: Sepsis”—Speaking with One Voice

  • Christopher J. Czura
Commentary

In the first half of the 20th century, the polio pandemic spread across much of the world, afflicting hundreds of thousands each year. Mounting a response to this global health crisis required consensus, common language, and dedication among lawmakers, philanthropists, industrialists, patient advocates, and healthcare providers. A diverse group from many industries, both public and private, collaborated to develop a comprehensible message that defined the problem of polio, described its prevalence and mortality, and communicated the barriers to diagnosing and treating it effectively. Together this group led an effort to develop treatment strategies that, fifty years later, have nearly eradicated this devastating and lethal disease.

There is another pandemic today that, like polio, requires a concerted effort across multiple business sectors to be defeated. Sepsis may be the final common pathway to death from most infections, and is estimated to kill tens of millions of people worldwide...

References

  1. 1.
    Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303–10.CrossRefGoogle Scholar
  2. 2.
    Linde-Zwirble WT, Angus DC. (2004) Severe sepsis epidemiology: Sampling, selection, and society. Crit. Care. 8:222–6.CrossRefGoogle Scholar
  3. 3.
    Dombrovskiy VY, et al. (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit. Care Med. 35:1414–5.CrossRefGoogle Scholar
  4. 4.
    Martin GS, et al. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546–54.CrossRefGoogle Scholar
  5. 5.
    Parrish WR, Gallowitsch-Puerta M, Czura CJ, Tracey KJ. (2008) Experimental therapeutic strategies for severe sepsis: mediators and mechanisms. Ann. N. Y. Acad. Sci. 1144:210–36.CrossRefGoogle Scholar
  6. 6.
    Dellinger RP, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 32:858–73.CrossRefGoogle Scholar
  7. 7.
    Dellinger RP, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36:296–327.CrossRefGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2011

Authors and Affiliations

  1. 1.The Feinstein Institute for Medical ResearchNorth Shore-LIJ Health SystemManhassetUSA

Personalised recommendations